Vivus (VVUS), a pharmaceutical company, July 6 puts have a 15% premium (.90). Since the stock is at 9.68 that represents about 47% downside protection (6-.90/9.68).
The July 5 put is at .50, a 10% premium with about 54% protection.
Obviously a very volatile stock and there are some serious upcoming FDA issues, but these are very interesting numbers.
Any thoughts?
Lou
__._,_.___
MARKETPLACE
.
__,_._,___
No comments:
Post a Comment